Literature DB >> 9459146

Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.

J Bussink1, J H Kaanders, P F Rijken, C A Martindale, A J van der Kogel.   

Abstract

A method is presented in this report for concurrent analysis of vascular architecture, blood perfusion and proliferation characteristics in whole-tumour cross-sections of human larynx carcinoma and glioblastoma xenografts. Tumours were implanted subcutaneously in nude mice. After i.v. injection with Hoechst 33342 and bromodeoxyuridine (BrdUrd) as perfusion and proliferation markers, animals were killed. An antiendothelial antibody (9F1) was used to delineate vascular structures. Cross-sections were analysed by a multistep immune staining and a computer-controlled microscope scanning method. Each tumour section was stained and scanned four times (Hoechst, 9F1, BrdUrd and Fast Blue for all nuclei). When these images were combined, vasculature, perfusion and proliferation parameters were analysed. The labelling index (LI) was defined as the ratio of the BrdUrd-labelled area to the total nuclear area. The LI based on manual counting and the LI calculated by flow cytometry (FCM) were in good agreement with the LI based on surface analysis. LI decreased at increasing distance from its nearest vessel. In the vicinity of perfused vessels, the LI was 30-70% higher than near non-perfused vessels. This method shows that both vasculature/perfusion and proliferation characteristics can be measured in the same whole-tumour section in a semiautomatic way. This could be applied in clinical practice to identify combined human tumour characteristics that predict for a favourable response to treatment modifications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459146      PMCID: PMC2151270          DOI: 10.1038/bjc.1998.9

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  Overcoming tumour radiation resistance resulting from acute hypoxia.

Authors:  M R Horsman; J Overgaard
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

Authors:  R A Gatenby; H B Kessler; J S Rosenblum; L R Coia; P J Moldofsky; W H Hartz; G J Broder
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

3.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

4.  Tumour cell proliferation in relation to the vasculature.

Authors:  D G Hirst; J Denekamp
Journal:  Cell Tissue Kinet       Date:  1979-01

5.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.

Authors:  A Asai; S Shibui; M Barker; M Vanderlaan; J W Gray; T Hoshino
Journal:  J Neurosurg       Date:  1990-08       Impact factor: 5.115

7.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

8.  The hazard of accelerated tumor clonogen repopulation during radiotherapy.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

9.  Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.

Authors:  M H Bennett; G D Wilson; S Dische; M I Saunders; C A Martindale; B M Robinson; A E O'Halloran; M D Leslie; J H Laing
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse.

Authors:  H J Bernsen; P F Rijken; T Oostendorp; A J van der Kogel
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

View more
  14 in total

1.  Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma.

Authors:  Giulio Gambarota; H W M van Laarhoven; M Philippens; W J M Peeters; P Rijken; A van der Kogel; C J A Punt; A Heerschap
Journal:  Appl Magn Reson       Date:  2010-03-28       Impact factor: 0.831

2.  Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.

Authors:  H W M van Laarhoven; G Gambarota; A Heerschap; J Lok; I Verhagen; A Corti; S Toma; C Gallo Stampino; A van der Kogel; C J A Punt
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

3.  Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.

Authors:  Hanneke Stegeman; Paul N Span; Paul F J W Rijken; Simone C Cockx; Deric L Wheeler; Mari Iida; Albert J van der Kogel; Johannes H A M Kaanders; Johan Bussink
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

4.  Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.

Authors:  Xiang Yuan; Jiangtu He; Fenyong Sun; Jiang Gu
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 5.  Restriction of drug transport by the tumor environment.

Authors:  Rajender Nandigama; Berin Upcin; Bertal H Aktas; Süleyman Ergün; Erik Henke
Journal:  Histochem Cell Biol       Date:  2018-10-25       Impact factor: 4.304

6.  Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.

Authors:  K I Wijffels; J H Kaanders; P F Rijken; J Bussink; F J van den Hoogen; H A Marres; P C de Wilde; J A Raleigh; A J van der Kogel
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

7.  Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.

Authors:  Jeannette C Oosterwijk-Wakka; Mirjam C A de Weijert; Gerben M Franssen; William P J Leenders; Jeroen A W M van der Laak; Otto C Boerman; Peter F A Mulders; Egbert Oosterwijk
Journal:  Neoplasia       Date:  2015-02       Impact factor: 5.715

Review 8.  Broad targeting of angiogenesis for cancer prevention and therapy.

Authors:  Zongwei Wang; Charlotta Dabrosin; Xin Yin; Mark M Fuster; Alexandra Arreola; W Kimryn Rathmell; Daniele Generali; Ganji P Nagaraju; Bassel El-Rayes; Domenico Ribatti; Yi Charlie Chen; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Somaira Nowsheen; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Bill Helferich; Xujuan Yang; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Dorota Halicka; Sulma I Mohammed; Asfar S Azmi; Alan Bilsland; W Nicol Keith; Lasse D Jensen
Journal:  Semin Cancer Biol       Date:  2015-01-16       Impact factor: 15.707

9.  17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response.

Authors:  E C Chinje; K J Williams; B A Telfer; P J Wood; A J van der Kogel; I J Stratford
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

10.  Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.

Authors:  Bianca A W Hoeben; Maud H W Starmans; Ralph T H Leijenaar; Ludwig J Dubois; Albert J van der Kogel; Johannes H A M Kaanders; Paul C Boutros; Philippe Lambin; Johan Bussink
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.